Show banner
Glucose Tolerance Test Market Research Report - Global Forecast till 2023

Global Glucose Tolerance Test Market: Information by Product (Blood Glucose Testing Kit [Lancet, Meters and Test Strips], Smart Sensors and others), Indication (Diabetes, Gestational Diabetes, Insulin Resistance and Reactive Hypoglycemia), End User (Diagnostic Clinics, Hospitals and Home) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

ID: MRFR/LS/3490-CR | July 2019 | Region: Global | 117 pages

Overview


The Global Glucose Tolerance Test Market is expected to grow at CAGR of 10.4% to reach USD 46,815.0 Million till 2023. A glucose tolerance test measures how well a body’s cells is capable to engross glucose, or sugar, after a patient consume a given amount of sugar. Doctors and specialists use fasting blood sugar levels and haemoglobin A1c values to identify type 1 and type 2 diabetes, and pre-diabetes whereas a glucose tolerance test can also be used. Doctors primarily use a glucose tolerance test to diagnose gestational diabetes in patients. The factors that are anticipated to propel the growth of the global glucose tolerance test market are increasing prevalence and incidence of diabetes mellitus (DM), innovation in technology, research funding in diabetes diagnosis & treatment, and rising awareness & screening for diabetes mellitus. However, the stringent reimbursement and insurance policies in developing nations, high-cost associated with diagnosis and treatment of diabetes can hamper the market growth in coming future.


Market Dynamics


Rising prevalence and incidence of diabetes mellitus, technological innovations, research funding in diabetes diagnosis & treatment, and awareness & screening for diabetes mellitus are the factors that drive the growth of glucose tolerance tests market. For instance, according to report published by WHO, in 2016, 1.6 million deaths were directly caused by diabetes worldwide. Also, according to the diabetes prevalence figures suggested by the Australian Bureau of Statistics, more than 5.1% of the Australian population diagnosed with diabetes in 2016. Various government and private associations in developed and some developing countries are contributing towards diabetes research and prevention programs. Various researchers have pioneered new devices to diagnose and treat diabetes, which on their own have significant market potential. The main aim of these association is to support and encourage research in the field of diabetes with the rapid diffusion of acquired knowledge to facilitate its application. The spending on diabetes care research ultimately leads to the healthcare delivery.


GLOBAL GLUCOSE TOLERANCE TEST MARKET BY PRODUCTS, 2016 & 2023 (USD MILLION)
 Glucose Tolerance Test Market


Sources: MRFR Analysis


Segmentation


On the basis of product, the global glucose tolerance test market has been segmented into blood glucose testing kit, smart sensors, and others. Blood glucose testing kit segment has been further segmented into lancet, meters, test strips, and others. Blood glucose testing kit is the leading segment, which is expected to hit USD 36,164.0 Million by the end of 2023. The large market share of blood glucose testing kit is due to the easily availability and use, rising prevalence of diabetes and growing demand of home care for diabetes. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes is responsible for about 90% to 95% of all diagnosed cases of diabetes in adults, further 29.1 million people in the United States have diabetes, but 8.1 million of the diagnosed may be unaware of their condition.


The global glucose tolerance test market, by indication, has been segmented into diabetes, gestational diabetes, insulin resistance, and reactive hypoglycemia. The diabetes segment is expected to show the highest CAGR 10.7% during the forecast period owing to the rising prevalence of diabetes. For instance, according to report published by CDC, in 2015, an estimated 1.5 million new cases of diabetes were diagnosed among people ages 18 and older.


On the bases of end-user market is segmented into diagnostic clinics, hospitals, and home. The diagnostic clinics are expected to hold the largest market share of 34.5% in 2016.


Key Players


The prominent players in the global glucose tolerance test market are Panasonic, Dexcom, Inc., Abbott Laboratories, F. Hoffman-La Roche Ltd, LifeScan, Inc., Sanofi, Medtronic PLC, and Others


Global Glucose Tolerance Test Market Share, by Region, 2016 (%)
 Glucose Tolerance Test Market


Sources: MRFR Analysis


Regional Analysis


The global glucose tolerance test market is mainly categorized as the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas is likely to dominate the global glucose tolerance test market with market share of 36.9% owing to the to the increasing prevalence of diabetes mellitus (DM), well-developed technology, and high healthcare expenditure. According to the American Diabetes Association, nearly 30 million Americans are dealing with diabetes and every 21 seconds one person is diagnosed with diabetes.


The European glucose tolerance test market has been segmented into Western Europe and Eastern Europe. Western Europe has been further segmented into Germany, France, Italy, Spain, UK, and the rest of Western Europe. Europe holds the second largest market share in the Western Europe region due to the increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population.


Asia-Pacific region expected to register the highest CAGR of 11.0% during the forecast period owing to rapidly changing healthcare sector, and the presence of huge opportunities for the development of this market.


Middle East & Africa is expected to witness a restricted growth due to presence of poor and slow developing countries, especially, in African region.


Some of the key strategies followed by the players operating in the global glucose tolerance test market were innovation, product development, acquisition, and expansion.



  • In Jan 2016, Panasonic Healthcare Holdings, Co., Ltd announced the completion of Panasonic Healthcare’s acquisition of Bayer AG’s Diabetes Care business.



  • In Sep 2016, Abbott received the approval from the US Food and Drug Administration (FDA) for FreeStyle Libre Pro system.


Market Segmentation


Global Glucose Tolerance Test Market, by Product



  • Blood Glucose Testing Kit

    • Lancet

    • Meters

    • Test strips

    • Others

    • Smart Sensors



  • Others


Global Glucose Tolerance Test Market, by Indication



  • Diabetes

  • Gestational Diabetes

  • Insulin Resistance

  • Reactive Hypoglycemia


Global Glucose Tolerance Test Market, by End User



  • Diagnostic Clinics

  • Hospitals

  • Home


Global Glucose Tolerance Test Market, by Region



  • North America

    • US

    • Canada

    • South America





  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Western Europe



    • Western Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • UAE

    • Saudi Arabia

    • Oman

    • Kuwait

    • Qatar

    • Rest of Middle East & Africa



Available Additional Customizations

Intended Audience



  • pharmaceutical companies

  • medical devices manufacturer

  • research and development (R&D) companies

  • market research and consulting service providers

  • potential investors



Frequently Asked Questions (FAQ) :

Glucose tolerance test market is projected to grow at a 10.4% CAGR between 2014-2023.

The Americas is expected to dominate the glucose tolerance test market.

Glucose tolerance test market is predicted to touch USD 46,815.0 million by 2023.

Diagnostic clinics will lead the glucose tolerance test market.

High cost of diagnosis may limit the glucose tolerance test market growth.

License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
USD YEN EURO GBP INR
TABLE OF CONTENT

2.1 Research Objective 14

2.2 Assumptions & Limitations 14

2.2.1 Assumptions 14

2.2.2 Limitations 14

2.3 Market Structure 15

3.1 Research Process 16

3.2 Primary Research 17

3.3 Secondary Research 17

3.4 Market Size Estimation 18

3.4.1 Trade Analysis 19

3.4.2 Market Pricing Approach 19

4.1 Drivers 20

4.1.1 Increasing prevalence and incidence of diabetes mellitus (DM) 20

4.1.2 Rise in technological innovations 21

4.1.3 Research funding in diabetes diagnosis and treatment 22

4.1.4 Rising awareness and screening for Diabetes Mellitus 23

4.2 Restraints 24

4.2.1 Stringent reimbursement and insurance policies in developing nations, can hamper the market growth in coming future 24

4.2.2 High cost associated with diagnosis and treatment of diabetes 25

4.3 Opportunities 26

4.4 Macroeconomic Indicators 27

5.1 Porter’s Five Forces Model 28

5.1.1 Bargaining Power of Suppliers 29

5.1.2 Bargaining Power of Buyers 29

5.1.3 Threat of New Entrants 29

5.1.4 Threat of Substitutes 29

5.1.5 Intensity of Rivalry 30

5.2 Value Chain Analysis 30

5.2.1 Raw Material 30

5.2.2 Supplier 31

5.2.3 Manufacturer 33

5.2.4 Distributer 33

5.2.5 Customer 34

5.2.6 Consumer 34

5.3 Demand & Supply: Gap Analysis 35

6.1 Introduction 36

6.2 Blood glucose testing kit 38

6.3 Smart sensors 38

7.1 Introduction 39

7.2 Diabetes 41

7.3 Gestational diabetes 41

7.4 Insulin resistance 42

7.5 Reactive hypoglycemia 42

8.1 Introduction 43

8.2 Diagnostic Clinics 44

8.3 Hospitals 45

8.4 Home 45

9.1 Introduction 46

9.2 Americas 47

9.2.1 North America 50

9.2.1.1 US 51

9.2.1.2 Canada 53

9.2.2 South America 54

9.3 Europe 56

9.3.1 Western Europe 58

9.3.1.1 Germany 60

9.3.1.2 France 61

9.3.1.3 Italy 63

9.3.1.4 Spain 64

9.3.1.5 UK 66

9.3.1.6 Rest of Western Europe 67

9.3.1.7 Eastern Europe 69

9.4 Asia Pacific 70

9.4.1 China 73

9.4.2 India 74

9.4.3 Japan 76

9.4.4 South Korea 78

9.4.5 Australia 79

9.4.6 Rest of Asia Pacific 81

9.5 Middle East & Africa 82

9.5.1 UAE 85

9.5.2 Saudi Arabia 86

9.5.3 Oman 88

9.5.4 Kuwait 89

9.5.5 Qatar 91

9.5.6 Rest of Middle East & Africa 92

10.1 Introduction 94

11.1 Panasonic 95

11.1.1 Company Overview 95

11.1.2 Financials 95

11.1.3 Products 95

11.1.4 Strategy 95

11.1.5 Key Developments 95

11.2 Dexcom, Inc. 96

11.2.1 Company Overview 96

11.2.2 Financials 96

11.2.3 Products 96

11.2.4 Strategy 96

11.2.5 Key Developments 96

11.3 Abbott Laboratories 97

11.3.1 Company Overview 97

11.3.2 Financials 97

11.3.3 Products 97

11.3.4 Strategy 97

11.3.5 Key Developments 97

97

11.4 F. Hoffman-La Roche Ltd 98

11.4.1 Company Overview 98

11.4.2 Financials 98

11.4.3 Products 98

11.4.4 Strategy 98

11.4.5 Key Developments 98

11.5 LifeScan, Inc. 99

11.5.1 Company Overview 99

11.5.2 Financials 99

11.5.3 Products 99

11.5.4 Strategy 99

11.5.5 Key Developments 99

11.6 Sanofi 100

11.6.1 Company Overview 100

11.6.2 Financials 100

11.6.3 Products 100

11.6.4 Strategy 100

11.6.5 Key Developments 100

11.7 Medtronic Plc 101

11.7.1 Company Overview 101

11.7.2 Financials 101

11.7.3 Products 101

11.7.4 Strategy 101

11.7.5 Key Developments 101

12.1 Key Findings 102

12.1.1 From CEO’s View Point 102

12.2 Key companies to watch 102

13.1 Discussion Blue Print 103

TABLE 1 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY PRODUCTS USD MILLION (2014-2023) 36

TABLE 2 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR BLOOD GLUCOSE TESTING KIT USD MILLION (2014-2023) 38

TABLE 3 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR SMART SENSORS USD MILLION (2014-2023) 38

TABLE 4 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 39

TABLE 5 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR DIABETES USD MILLION (2014-2023) 41

TABLE 6 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR GESTATIONAL DIABETES USD MILLION (2014-2023) 41

TABLE 7 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR INSULIN RESISTANCE USD MILLION (2014-2023) 42

TABLE 8 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR REACTIVE HYPOGLYCEMIA USD MILLION (2014-2023) 42

TABLE 9 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 43

TABLE 10 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR DIAGNOSTIC CLINICS USD MILLION (2014-2023) 44

TABLE 11 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR HOSPITALS USD MILLION (2014-2023) 45

TABLE 12 GLOBAL GLUCOSE TOLERANCE TEST MARKET FOR HOME USD MILLION (2014-2023) 45

TABLE 13 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY REGIONS USD MILLION (2014-2023) 46

TABLE 14 AMERICAS GLUCOSE TOLERANCE TEST MARKET BY REGIONS USD MILLION (2014-2023) 47

TABLE 15 AMERICAS GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 48

TABLE 16 AMERICAS GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 49

TABLE 17 AMERICAS GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 49

TABLE 18 NORTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 50

TABLE 19 NORTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 50

TABLE 20 NORTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 51

TABLE 21 US GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 51

TABLE 22 US GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 52

TABLE 23 US GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 52

TABLE 24 CANADA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 53

TABLE 25 CANADA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 53

TABLE 26 CANADA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 54

TABLE 27 SOUTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 54

TABLE 28 SOUTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 55

TABLE 29 SOUTH AMERICA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 55

TABLE 30 EUROPE GLUCOSE TOLERANCE TEST MARKET BY REGIONS USD MILLION (2014-2023) 56

TABLE 31 EUROPE GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 57

TABLE 32 EUROPE GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 57

TABLE 33 EUROPE GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 58

TABLE 34 WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 58

TABLE 35 WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 59

TABLE 36 WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 59

TABLE 37 GERMANY GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 60

TABLE 38 GERMANY GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 60

TABLE 39 GERMANY GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 61

TABLE 40 FRANCE GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 61

TABLE 41 FRANCE GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 62

TABLE 42 FRANCE GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 62

TABLE 43 ITALY GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 63

TABLE 44 ITALY GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 63

TABLE 45 ITALY GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 64

TABLE 46 SPAIN GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 64

TABLE 47 SPAIN GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 65

TABLE 48 SPAIN GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 65

TABLE 49 UK GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 66

TABLE 50 UK GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 66

TABLE 51 UK GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 67

TABLE 52 REST OF WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 67

TABLE 53 REST OF WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 68

TABLE 54 REST OF WESTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 68

TABLE 55 EASTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 69

TABLE 56 EASTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 69

TABLE 57 EASTERN EUROPE GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 70

TABLE 58 ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY REGIONS USD MILLION (2014-2023) 70

TABLE 59 ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 71

TABLE 60 ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 72

TABLE 61 ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 72

TABLE 62 CHINA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 73

TABLE 63 CHINA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 73

TABLE 64 CHINA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 74

TABLE 65 INDIA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 74

TABLE 66 INDIA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 75

TABLE 67 INDIA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 75

TABLE 68 JAPAN GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 76

TABLE 69 JAPAN GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 77

TABLE 70 JAPAN GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 77

TABLE 71 SOUTH KOREA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 78

TABLE 72 SOUTH KOREA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 78

TABLE 73 SOUTH KOREA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 79

TABLE 74 AUSTRALIA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 79

TABLE 75 AUSTRALIA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 80

TABLE 76 AUSTRALIA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 80

TABLE 77 REST OF ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 81

TABLE 78 REST OF ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 81

TABLE 79 REST OF ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 82

TABLE 80 MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY REGIONS USD MILLION (2014-2023) 82

TABLE 81 MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 83

TABLE 82 MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 84

TABLE 83 MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 84

TABLE 84 UNITED ARAB EMIRATES GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 85

TABLE 85 UNITED ARAB EMIRATES GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 85

TABLE 86 UNITED ARAB EMIRATES GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 86

TABLE 87 SAUDI ARABIA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 86

TABLE 88 SAUDI ARABIA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 87

TABLE 89 SAUDI ARABIA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 87

TABLE 90 OMAN GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 88

TABLE 91 OMAN GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 88

TABLE 92 OMAN GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 89

TABLE 93 KUWAIT GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 89

TABLE 94 KUWAIT GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 90

TABLE 95 KUWAIT GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 90

TABLE 96 QATAR GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 91

TABLE 97 QATAR GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 91

TABLE 98 QATAR GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 92

TABLE 99 REST OF MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY PRODUCT USD MILLION (2014-2023) 92

TABLE 100 REST OF MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY INDICATION USD MILLION (2014-2023) 93

TABLE 101 REST OF MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY END USERS USD MILLION (2014-2023) 93

FIGURE 1 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY PRODUCT MARKET SHARE 2016 (%) 12

FIGURE 2 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY INDICATION MARKET SHARE 2016 (%) 13

FIGURE 3 RESEARCH PROCESS 16

FIGURE 4 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY PRODUCTS 2017 & 2023 37

FIGURE 5 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY INDICATION 2017 & 2023 40

FIGURE 6 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY END USERS 2017 & 2023 44

FIGURE 7 GLOBAL GLUCOSE TOLERANCE TEST MARKET BY REGIONS MARKET SHARE 2016 (%) 47

FIGURE 8 AMERICAS GLUCOSE TOLERANCE TEST MARKET BY REGIONS MARKET SHARE 2016 (%) 48

FIGURE 9 EUROPE GLUCOSE TOLERANCE TEST MARKET BY REGIONS MARKET SHARE 2016 (%) 56

FIGURE 10 ASIA PACIFIC GLUCOSE TOLERANCE TEST MARKET BY REGIONS MARKET SHARE 2016 (%) 71

FIGURE 11 MIDDLE EAST & AFRICA GLUCOSE TOLERANCE TEST MARKET BY REGIONS MARKET SHARE 2016 (%) 83

FIGURE 12 GLOBAL GLUCOSE TOLERANCE TEST COMPANY MARKET SHARE 2016 (%) 94